NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Ekso Bionics Holdings Inc (EKSO) Stock Analysis

Ekso Bionics Holdings Inc (EKSO) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

EKSO

$11.80

+$0.15 (+1.29%)

Last trade May 15, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare EKSO with… →

EKSO Key Statistics

As of May 15, 2026
Trading
Open
$11.40
Previous Close
$11.65
52-Week Range
2.73–13.50
Volume
95.14K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.78
Valuation
Market Cap
$42.05M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.29
EPS (ttm)Profit attributable to each share over the last twelve months.
−5.11
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
−91.37%
1-Year Return
+96.67%
Dividend and dates
Avg Volume
78.94K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

EKSO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+36.57%
2025−27.00%

As of May 15, 2026.

EKSO Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricEKSOMedical Instruments & Supplies medianvs median
P/S ratio3.293.174% above
Profit margin−91.37%0.85%92.2 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Ekso Bionics Holdings Inc (EKSO) at $42.05M. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 50.

EKSO last closed at $11.80 on May 15, 2026. That is +$0.15 (+1.29%) against the previous close. The 52-week range on file runs from $2.73 to $13.50. The latest close sits 332.23% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is $12.80M. Profit margin runs at −91.37%. That is 92.2 percentage points below the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are −5.11.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 3.29. On price-to-sales that is 3.54% above the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.78. Daily returns over the trailing 1 year annualize to a volatility of 133.21%. Over the trailing twelve months the price has returned +96.67%.

Growth & Income

No dividend is on file for EKSO.

2026 is still running; the price is +36.57% year to date. The record holds one complete calendar year, 2025, which returned −27.00%.

Peer Comparison

Ekso Bionics Holdings Inc (EKSO) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Ekso Bionics Holdings Inc EKSO $42.05M —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Ekso Bionics Holdings Inc has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of May 15, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Visit website →